Search Results: Semglee
Redirect to:
- From or to a drug trade name: This is a redirect from (or to) the trade name of a drug to (or from) the international nonproprietary name (INN), the generic name or the nonproprietary name.
Insulin glargine
Selasa, 2026-06-30 19:58:02Administration (FDA) approved an interchangeable biosimilar insulin product called Semglee (insulin glargine-yfgn) for the treatment of diabetes. The long-acting...
Click to read more »Biocon
Senin, 2026-08-17 19:01:25$3.34 billion. In 2021, Biocon and Viatris received approval to launch Semglee, an insulin glargine-yfgn injection, the first interchangble biosimilar...
Click to read more »List of commercially available insulins
Jumat, 2026-07-03 20:37:33pharmaceutical companies also produce insulin, such as Mannkind (Afrezza), Viatris (Semglee), Lupin (Lupisulin), Baxter (Myxredlin), Biocon (Basalog), Darou Pakhsh...
Click to read more »Biosimilar
Jumat, 2026-06-26 21:27:16Archived from the original on April 2, 2022. Retrieved April 4, 2022. "Semglee EPAR". European Medicines Agency (EMA). May 23, 2018. Archived from the...
Click to read more »Pharmaceutical industry in India
Jumat, 2026-04-24 17:48:51Biocon Biologics, a subsidiary of Biocon, received USFDA approval for Semglee, which is the first interchangeable biosimilar insulin glargine. Another...
Click to read more »Insulin (medication)
Rabu, 2026-08-19 16:09:43approval and labeling. In July 2021, the FDA approved insulin glargine-yfgn (Semglee), a biosimilar product that contains the long acting analog insulin glargine...
Click to read more »Insulin analogue
Minggu, 2026-08-16 12:46:28insulin aspart-szjj. Insulin glargine-yfgn is marketed under the name Semglee, and received FDA approval in July 2021, but development began before that...
Click to read more »